Title: Metabolomics in Toxicology and Preclinical Research
Authors: RAMIREZ TzutzuyDANESHIAN MardasKAMP HennickeBOIS FredericCLENCH Malcolm R.COEN MuireannDONLEY BethFISCHER Steven M.EKMAN Drew R.FABIAN EricGUILLOU ClaudeHEUER JoachimHOGBERG Helena T.JUNGNICKEL HaraldKEUN Hector C.KRENNRICH GerhardKRUPP EckartLUCH AndreasNOOR FoziaPETER ErikRIEFKE BjoernSEYMOUR MarkSKINNER N.SMIRNOVA LenaVERHEIJ ElwinWAGNER SilviaHARTUNG ThomasVAN RAVENZWAAY BennardLEIST Marcel
Citation: ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION vol. 30 no. 2 p. 209-225
Publisher: SPEKTRUM AKADEMISCHER VERLAG-SPRINGER-VERLAG GMBH
Publication Year: 2013
JRC N°: JRC81545
ISSN: 1868-596X
URI: http://www.altex.ch/Current-issue.16.html?aid=6
http://publications.jrc.ec.europa.eu/repository/handle/JRC81545
Type: Articles in periodicals and books
Abstract: Metabolomics, the comprehensive analysis of metabolites in a biological system, provides detailed information about the biochemical/physiological status of a biological system, and about the changes caused by chemicals. Metabolomics analysis is used in many fields, ranging from the analysis of the physiological status of genetically modified organisms in safety science to the evaluation of human health conditions. In toxicology, metabolomics is the -omics discipline that is most closely related to classical knowledge of disturbed biochemical pathways. It allows rapid identification of the potential targets of a hazardous compound. It can give information on target organs and often can help to improve our understanding regarding the mode-of-action of a given compound. Such insights aid the discovery of biomarkers that either indicate pathophysiological conditions or help the monitoring of the efficacy of drug therapies. The first toxicological applications of metabolomics were for mechanistic research, but different ways to use the technology in a regulatory context are being explored. Ideally, further progress in that direction will position the metabolomics approach to address the challenges of toxicology of the 21st century. To address these issues, scientists from academia, industry, and regulatory bodies came together in a workshop to discuss the current status of applied metabolomics and its potential in the safety assessment of compounds. We report here on the conclusions of three working groups addressing questions regarding 1) metabolomics for in vitro studies 2) the appropriate use of metabolomics in systems toxicology, and 3) use of metabolomics in a regulatory context
JRC Directorate:Institute for Health and Consumer Protection Historical Collection

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.